跳至主要内容
临床试验/NCT00348582
NCT00348582已完成4 期

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Innovative Medical2 个研究点 分布在 1 个国家开始时间: 2006年7月4日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
试验地点
2

研究概览

简要总结

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • · Male or female > 18 years of age scheduled to undergo cataract surgery
  • Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams)
  • Ability to provide informed consent and likely to complete all study visits

排除标准

  • · Known contraindication to any study medication or any of their components
  • Uncontrolled systemic disease
  • Required use of ocular medications other than the study medications during the study
  • Abnormal pre-operative OCTs if obtainable
  • Diabetic patients
  • Use of oral NSAIDS
  • Patients with ocular disease (macula degeneration, glaucoma, corneal disease) which reduces the potential visual rehabilitation (patients will ocular disease that will no preclude achievement of a 20/20 visual outcome may be included)..

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Acular LS vs. Nevanac in Post op Inflammation... | 临床试验